These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36560689)

  • 21. Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2.
    Ali SG; Ansari MA; Alzohairy MA; Almatroudi A; Alomary MN; Alghamdi S; Rehman S; Khan HM
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33673004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation.
    Inagaki H; Saito A; Sugiyama H; Okabayashi T; Fujimoto S
    Emerg Microbes Infect; 2020 Dec; 9(1):1744-1747. PubMed ID: 32673522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D Printed Cobalt-Chromium-Molybdenum Porous Superalloy with Superior Antiviral Activity.
    Arjunan A; Robinson J; Baroutaji A; Tuñón-Molina A; Martí M; Serrano-Aroca Á
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.
    Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT
    J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection: Microbiologic perspectives and anatomic considerations for sanctuary sites.
    Azu OO; Olojede SO; Lawal SK; Oseni SO; Rennie CO; Offo U; Naidu ECS
    J Infect Public Health; 2021 Sep; 14(9):1237-1246. PubMed ID: 34455307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized parameters for effective SARS-CoV-2 inactivation using UVC-LED at 275 nm.
    Lee C; Park KH; Kim M; Kim YB
    Sci Rep; 2022 Oct; 12(1):16664. PubMed ID: 36198702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral properties of copper and its alloys to inactivate covid-19 virus: a review.
    Govind V; Bharadwaj S; Sai Ganesh MR; Vishnu J; Shankar KV; Shankar B; Rajesh R
    Biometals; 2021 Dec; 34(6):1217-1235. PubMed ID: 34398357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Different Temperature and Time Durations of Virus Inactivation on Results of Real-time Fluorescence PCR Testing of COVID-19 Viruses.
    Wu ZG; Zheng HY; Gu J; Li F; Lv RL; Deng YY; Xu WZ; Tong YQ
    Curr Med Sci; 2020 Aug; 40(4):614-617. PubMed ID: 32767258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2).
    Belem WF; Liu CH; Hu YT; Burnouf T; Lin LT
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential inhibitors of SARS-CoV-2: recent advances.
    Jamalipour Soufi G; Iravani S
    J Drug Target; 2021 Apr; 29(4):349-364. PubMed ID: 33210953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Gupta D; Parthasarathy H; Sah V; Tandel D; Vedagiri D; Reddy S; Harshan KH
    Virus Res; 2021 Nov; 305():198555. PubMed ID: 34487766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ozone based inactivation and disinfection in the pandemic time and beyond: Taking forward what has been learned and best practice.
    Cai Y; Zhao Y; Yadav AK; Ji B; Kang P; Wei T
    Sci Total Environ; 2023 Mar; 862():160711. PubMed ID: 36496014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of photodynamic therapy as an antiviral treatment: Potential guidance for dealing with SARS-CoV-2.
    Conrado PCV; Sakita KM; Arita GS; Galinari CB; Gonçalves RS; Lopes LDG; Lonardoni MVC; Teixeira JJV; Bonfim-Mendonça PS; Kioshima ES
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102221. PubMed ID: 33601001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
    Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
    Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral Activity of the Propylamylatin
    Brown AN; Strobel G; Hanrahan KC; Sears J
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.